Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis    NOVN   CH0012005267

NOVARTIS (NOVN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest news on NOVARTIS
10/24 NOVARTIS : beats 3Q profit forecasts
10/24DJNOVARTIS : 3Q Net Profit Rises as New Drugs Offset Generic Competition
10/24 NOVARTIS : delivered growth on top and bottom line in all divisions in Q3
10/24 NOVARTIS : delivered growth on top and bottom line in all divisions in Q3
10/23DJEuropean Corporate Roundup for Monday
10/23DJDrug Makers Find 'Branded Generics' Are a Source for Growth
10/23DJEuropean Corporate Roundup for Monday
10/23DJNOVARTIS : Melanoma Treatment Awarded FDA Breakthrough Designation
10/23 NOVARTIS : combination adjuvant therapy Tafinlar® + Mekinist® receives FDA Break..
10/20 NOVARTIS : To shut us generics plant, cut 450 jobs
10/19 NOVARTIS : Recent Findings from Novartis Provide New Insights into Glucosyltrans..
10/19 GILEAD SCIENCES : 2nd gene therapy for blood cancer approved
10/19 NOVARTIS : Drug Revolade(R) Shows Long-Term Disease Control for Chronic/Persiste..
10/19 NOVARTIS : sheds generics plant and 450 jobs amid pricing pressure
10/19 NOVARTIS : FDA OKs 2nd gene therapy for blood cancer; 1st for adults
10/18 NOVARTIS : 450 jobs to go as pricing pressures push Novartis to close CO generic..
10/18 NOVARTIS : drug Revolade® shows long-term disease control for chronic/persistent..
10/13 NOVARTIS : Alcon Laboratories, Inc. Constellation LXT Vitrectomy/ Vitreoretinal ..
10/13 NOVARTIS : 65-- Alcon Laboratories, Inc. Constellation LXT Vitrectomy/ Vitreoret..
10/13 NOVARTIS AG (ADR)(NYSE : NVS) Says It Will Not Sell Its Stake In Roche
10/13 NOVARTIS : Alcon Centurion Analyzers (Optometry) | 10/1/17 - 093018 ultimate end..
10/12 NOVARTIS : Argentum Pharmaceuticals Succeeds in Starting Patent Cancellation Tri..
10/11 NOVARTIS : decides not to sell Roche stake chairman tells newspaper
10/11 NOVARTIS : Alcon Centurion Analyzers (Optometry) | 10/1/17 - 093018 ultimate end..
10/11 NOVARTIS : J-- Alcon Centurion Analyzers (Optometry) | 10/1/17 - 093018 ultimate..
10/11 NOVARTIS : Foundation launches Healthy Schools for Healthy Communities with the ..
10/11 NOVARTIS : Foundation launches Healthy Schools for Healthy Communities with the ..
10/10 NOVARTIS : Alcon receives CE Mark for first of its kind AutonoMe preloaded intra..
10/08 NOVARTIS : Federal Contracts Awarded by Federal Agencies in Hawaii (Oct. 8)
10/06 NOVARTIS : Alcon receives CE Mark for first-of-its-kind AutonoMe(TM) preloaded i..
10/06 NOVARTIS : Divests anti-infectives brands to samara capital
10/05 NOVARTIS : Patent Issued for Wavefront Correction for Ophthalmic Surgical Lasers..
10/05 NOVARTIS : Researchers at Novartis Report New Data on Medicinal Chemistry [Disco..
10/05 TEVA PHARMACEUTICAL INDUSTRIES : FDA Approves Two New Generic Forms of Copaxone(..
10/05 NOVARTIS : MILITARY $58,354 Federal Contract Awarded to Alcon Laboratories
10/04 NOVARTIS : INTENT TO SOLE source
10/04 NOVARTIS : KHCC, Novartis Pharma AG sign cooperation agreement
10/04 NOVARTIS : Argentum Pharmaceuticals Succeeds in Starting Patent Cancellation Tri..
10/03 NOVARTIS : Heart failure caregivers face critical gaps in resources and support,..
10/02 NOVARTIS : and UC Berkeley collaborate to tackle 'undruggable' disease targets
10/02 NOVARTIS : Alcon introduces new innovations in cataract surgery at European Soci..
10/01 NOVARTIS : Federal Contracts Awarded by Federal Agencies in Hawaii (Oct. 1)
09/30 NOVARTIS : MILITARY $1.02 Million Federal Contract Awarded to Alcon Laboratories
09/29 NOVARTIS : UC Berkeley Collaborate to Tackle `Undruggable` Disease Targets
09/28 NOVARTIS : Patent Issued for Asymmetric Capsular Ring for Inhibiting Capsular Op..
09/28 NOVARTIS : Patent Issued for Plunger Tip Coupling Device for Intraocular Lens In..
09/28 NOVARTIS : Patent Issued for Ocular Implant with Stiffness Qualities, Methods of..
09/28 NOVARTIS : Patent Issued for Flow Promoting Ocular Implant (USPTO 9763829)
09/28 NOVARTIS : Preventive Maintenance Checks and Services for ALCON Excimer Ophthalm..
09/28 NOVARTIS : Access and government of Cameroon sign memorandum of understanding to..
09/28 NOVARTIS : Access and government of Cameroon sign memorandum of understanding to..
09/28 NOVARTIS : forges UC Berkeley pact, sees drug hopefuls in three years
09/28 NOVARTIS : and UC Berkeley collaborate to tackle 'undruggable' disease targets
09/27 NOVARTIS AG : Edison Issues Free Strategic Overview On Future of T-Cell Therapie..
09/26 NOVARTIS : wins 1st place at the SAMS Europe Award 2017 with "Cloud SAM for Sale..
09/26 NOVARTIS INDIA : continues to slide post buyback approval
09/26 NOVARTIS : Sandoz Releases New Clinical Study Data for Adalimumab Biosimilar
09/26 NOVARTIS INDIA : board clears share buyback worth Rs 231 cr
09/26 NOVARTIS INDIA : BOARD APPROVES Rs231-CRORE SHARE BUYBACK
09/26 NOVARTIS INDIA : BOARD APPROVES Rs231-CR SHARE BUYBACK PLAN
09/25 NOVARTIS INDIA : down by 8%, board approves share buyback
09/22 NOVARTIS AG : Corporate News Blog - Novartis Receives EC’s Approval for Rydapt; ..
09/22 NOVARTIS : and The Max Foundation transform pioneering cancer access program for..
09/21 NOVARTIS : Sandoz proposed biosimilar rituximab accepted for review by the FDA
09/21 NOVARTIS : Findings from Novartis Provides New Data about Mononuclear Leukocytes..
09/21 NOVARTIS : Patent Issued for Soft Tip Cannula (USPTO 9757536)
09/21 NOVARTIS : teams up with actress, producer and activist Eva Longoria to launch K..
09/21 NOVARTIS : Cosentyx® sets the new benchmark in psoriasis with robust 5-year sust..
09/21 NOVARTIS : Studies in the Area of Psoriatic Arthritis Reported from Novartis (Mi..
09/21 NOVARTIS : Recent Findings from Novartis Provide New Insights into Molecular Mod..
09/21 NOVARTIS : New analysis shows Entresto improved physical and social activity in ..
09/21 NOVARTIS INDIA : to consider buyback of equity shares
09/20 NOVARTIS : drug Rydapt® (midostaurin) receives EU approval for newly diagnosed F..
09/18 NOVARTIS : Physicians' skills in diabetes diagnosis, management enhanced with co..
09/18 NOVARTIS' : Xolair® confirms re-treatment efficacy in chronic spontaneous urtica..
Prev.1   2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2017 49 139 M
EBIT 2017 11 811 M
Net income 2017 7 375 M
Debt 2017 17 810 M
Yield 2017 3,37%
P/E ratio 2017 24,14
P/E ratio 2018 21,17
EV / Sales 2017 4,83x
EV / Sales 2018 4,62x
Capitalization 219 B
Chart NOVARTIS
Duration : Period :
Novartis Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Technical analysis trends NOVARTIS
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 32
Average target price 87,3 $
Spread / Average Target 3,5%
EPS Revisions
Managers
NameTitle
Joseph Jimenez Chief Executive Officer
Hans Jörg Reinhardt Independent Non-Executive Chairman
Harry Kirsch Chief Financial Officer
Vasant Narasimhan Chief Medical Officer & Head-Drug Development
Srikant Madhav Datar Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
NOVARTIS11.20%219 321
JOHNSON & JOHNSON19.78%370 740
PFIZER8.90%210 830
ROCHE HOLDING LTD.-1.55%200 193
MERCK AND COMPANY-6.23%150 550
AMGEN16.27%123 405